Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time-Reference-Cited by-同舟云学术

Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time

Published:2021-06-17 Issue:5 Volume:27 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Stonebraker Jeffrey S.¹^ORCID,O'Mahony Brian²^ORCID,Noone Declan³,Iorio Alfonso⁴⁵^ORCID

Affiliation:

1. Department of Business Management Poole College of Management North Carolina State University Raleigh North Carolina USA

2. Irish Haemophilia Society, Dublin, Trinity College Dublin Ireland

3. European Haemophilia Consortium Brussels Belgium

4. Department of Health Research Methods, Evidence, and Impact, Mike Gent Chair in HealthCare Research McMaster University Hamilton Ontario Canada

5. Department of Medicine McMaster University Hamilton Ontario Canada

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14364

Reference42 articles.

1. A study of reported factor VIII use around the world

2. A study of reported factor IX use around the world

3. The World Federation of Hemophilia Annual Global Survey 1999‐2018

4. The impact of extended half-life versus conventional factor product on hemophilia caregiver burden

5. Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining success in haemophilia care – Are we doing it right?;Haemophilia;2024-03-18

2. Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B;Cochrane Database of Systematic Reviews;2024-02-27

3. A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis;Thrombosis and Haemostasis;2023-02-09